All Stories

  1. In Silico Pharmacogenomic Assessment of Glucagon-like Peptide-1 (GLP1) Agonists and the Genetic Addiction Risk Score (GARS) Related Pathways: Implications for Suicidal Ideation and Substance Use Disorder

    Article • Current Neuropharmacology, July 2025, Bentham Science Publishers

    Alireza Sharafshah, Professor kenneth Blum, Prof. Sergio Schmidt, Rajendra Badgaiyan, ROSSANO FIORELLI, Prof. Abdalla Bowirrat

  2. Using science to fix addiction forever - Reward Deficiency Syndrome Solutions

    Article • Current Pharmaceutical Biotechnology, January 2024, Bentham Science Publishers

    Professor kenneth Blum, Rajendra Badgaiyan, ELIZABETH GILLEY, Prof. Abdalla Bowirrat

  3. Dopaminylation in Psychostimulant Use Disorder Protects Against Psychostimulant Seeking Behavior by Normalizing Nucleus Accumbens (NAc) Dopamine Expression

    Article • Current Psychopharmacologye, April 2022, Bentham Science Publishers

    Professor kenneth Blum, Rajendra Badgaiyan, Marjorie Gondre-Lewis, Prof. Abdalla Bowirrat

  4. Endorphinergic Enhancement Attenuation of Post-traumatic Stress Disorder (PTSD) via Activation of Neuro-immunological Function in the Face of a Viral Pandemic

    Article • Current Psychopharmacologye, June 2021, Bentham Science Publishers

    Professor kenneth Blum, Rajendra Badgaiyan, Prof. Abdalla Bowirrat